TEI-6472

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameTEI-6472

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistamine release inhibitors

TargetsUpdating

Therapy Area/IndicationsAllergic asthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTeijin Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTeijin Pharma

Active IndicationsN/A

Inactive IndicationsAllergic asthma

ATC CodeN/A